| Literature DB >> 24900215 |
Maria A Cinellu1, Laura Maiore1, Mario Manassero2, Angela Casini3, Massimiliano Arca4, Heinz-Herbert Fiebig5, Gerhard Kelter5, Elena Michelucci6, Giuseppe Pieraccini6, Chiara Gabbiani7, Luigi Messori7.
Abstract
A novel dioxo-bridged dinuclear gold(III) complex with two 2,9-dimethylphenanthroline ligands was synthesized and thoroughly characterized. Its crystal structure was solved, and its solution behavior assessed. Remarkably, this compound revealed excellent antiproliferative properties in vitro against a wide panel of 36 cancer cell lines, combining a high cytotoxic potency to pronounced tumor selectivity. Very likely, these properties arise from an innovative mode of action (possibly involving histone deacetylase inhibition), as suggested by COMPARE analysis. In turn, electrospray ionization-mass spectrometry studies provided valuable insight into its molecular mechanisms of activation and of interaction with protein targets. Gold(III) reduction, dioxo bridge disruption, coordinative gold(I) binding to the protein, and concomitant release of the phenanthroline ligand were proposed to occur upon interaction with superoxide dismutase, used here as a model protein. Because of the reported results, this new gold(III) compound qualifies itself as an optimal candidate for further pharmacological testing.Entities:
Keywords: COMPARE analysis; Cytotoxic gold compounds; anticancer agents; protein targets
Year: 2010 PMID: 24900215 PMCID: PMC4007953 DOI: 10.1021/ml100097f
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345